CCO Interactive Case Challenges
CCO Interactive Case Challenges: Diagnosis and Treatment of Cutaneous T-Cell Lymphoma
Interactive Case Challenges
Treatment of Early-Stage CTCL in a 56-Year-Old Black Male Patient
|
|
|
Along with John A. Zic, MD, investigate the diagnosis of mycosis fungoides and review the treatment options available for patients with early-stage disease.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the diagnosis of early-stage mycosis fungoides
- Review potential drug-drug interactions in the treatment of CTCL
- Discuss treatment options, including topical and systemic therapies, for newly diagnosed CTCL
|
Treatment of a 54-Year-Old Male With Tumor-Stage Mycosis Fungoides
- Francine Foss, MD, PhD, FACP
|
|
|
Francine Foss, MD, reviews optimal management of a highly functional patient presenting with de novo tumor-stage mycosis fungoides.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify the quality-of-life and adverse effect issues involved in first-line treatment of a highly functional patient with tumor-stage mycosis fungoides and preexisting medical conditions
- Describe the use of immunosuppressive vs nonimmunosuppressive approaches as second-line treatment for patients with tumor-stage mycosis fungoides
- Discuss the use of targeted approaches to treatment in cutaneous T-cell lymphoma
|
Treatment of Recurrent Folliculotropic Mycosis Fungoides in a 37-Year-Old Black Female Patient
 
- Madeleine Duvic, MD
- Payal Patel, DO
|
|
|
Along with Dr Madeleine Duvic, MD, investigate the treatment of advanced folliculotropic mycosis fungoides and review the options available for patients with multiply relapsed disease.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the characteristics that distinguish folliculotropic mycosis fungoides from other forms of cutaneous T-cell lymphoma
- Review second-line treatment options for patients with folliculotropic mycosis fungoides
- Review management options for specific adverse effects of treatment in multiply relapsed advanced mycosis fungoides
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|